SurGenTec receives FDA clearance for OsteoFlo HydroPutty, a hydrophilic synthetic bone graft.

SurGenTec announces FDA clearance for its OsteoFlo HydroPutty, a hydrophilic synthetic bone graft. The innovative product features proprietary hydrophilic carriers designed to absorb fluids like bone marrow aspirate, blood or saline, turning into putty for superior handling characteristics and a resorption profile optimized for bone growth. The company reports first implantations of the new graft and considers it a significant advancement in bone graft technology.

March 07, 2024
3 Articles

Further Reading